IRMD EBITDA Growth
15.09%TTM
Period ending:
IRMD TTM EBITDA YoY %%
2061.30%-325.22%
2014-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
IRMD ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 47 observations from Dec 31, 2014 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 15.0906% | |
| 22.7022% | |
| 17.6714% | |
| 14.1324% | |
| 9.8512% | |
| 9.9069% | |
| 13.2309% | |
| 20.4894% | |
| 33.031% | |
| 33.5866% | |
| 31.5083% | |
| 24.1348% | |
| 21.5677% | |
| 38.8904% | |
| 49.8067% | |
| 86.9936% | |
| 135.2233% | |
| 684.9516% | |
| 1,830.3477% | |
| 313.6986% | |
| 64.017% | |
| -82.6166% | |
| -94.2703% | |
| -78.2316% | |
| -52.5451% | |
| 22.0332% | |
| 43.068% | |
| 51.772% | |
| 56.3985% | |
| 115.3128% | |
| 283.3417% | |
| 206.5189% | |
| 21.6355% | |
| -52.4475% | |
| -83.3037% | |
| -83.8927% | |
| -68.1564% | |
| -42.8366% | |
| -5.37% | |
| 50.5874% | |
| 135.1438% | |
| 176.6468% | |
| 265.0789% | |
| 132.1639% | |
| 59.0343% | |
| 66.7415% | |
| 9.8651% |
Compare ebitda growth
All IRMD financial metrics · IRMD stock overview · How to interpret financial metrics
